IFH CONSULTING AS

Operating

Drive rådgivning og konsulenttjenester til legemiddelselskap og/eller Biotech innen utvikling og kommersialisering av legemiddel og medisinsk utstyr.

Konsulenttjenester og rådgivning i forbindelse med utvikling av nye legemidler/medisinsk utstyr til godkjenning av helsemyndigheter og/eller videre utvikling og kommersialisering av godkjente legemidler. Tjenestene vil i all hovedsak være rettet mot farmasøytisk bedrifter/biotek i Norge eller utlandet og/eller mot bedrifter som utvikler/produserer medisinsk utstyr

Keywords

engineering servicespowerenergytransportwatersewagedrainageindustrymanufacturingtelecommunicationsbroadcastingpolicy analysisregulationsexpert opinionswitness statementsmechanical engineeringautomotive engineeringchemical engineeringtechnical consulting

Organization

CEO: IC
Inger Charlotte Ferner Heglund1955
Chairman of the board: IC
Inger Charlotte Ferner Heglund1955
Years since formation: 8 years; since Aug 10, 2018
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 100; 1 share class
Total number of shareholders: 1; person

Financials

Total operating income 2025: 560,350; NOK
Annual total result 2025: -236,503; NOK
Total equity 2025: 2,384,691; NOK

Last update: May 16, 2026

Management

Management / administration

Name	Role	Shares
IC Inger Charlotte Ferner Heglund 1955	Managing Director/CEO	100 % directly

Board

Name	Role	Shares
IC Inger Charlotte Ferner Heglund 1955	Chairman	100 % directly
KH Kim Hjalmar Heglund 1951	Board Member	-

Others

Name	Role	Shares
S SOLIDITET AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
IC Inger Charlotte Ferner Heglund 1955	Managing Director/CEO, Chairman	100 % directly

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
IC Inger Charlotte Ferner Heglund 1955	Ordinary shares	100	100 %

Shares owned by the IFH CONSULTING AS

Name	Share class	Total number of shares	Share
S SERCA PHARMACEUTICALS AS	Ordinary shares	22,260	2.49 %
N NOWWELL HOLDING AS Under liquidation	Ordinary shares	732	0.25 %

Last update: Jun 2, 2025

Financials

in NOK

Summary

Year	2025	2024	2023	2022
Total operating income	560,350	936,700	1,340,450	1,260,450
Annual Total Result	-236,503	111,714	430,851	385,079
Total assets	2,578,326	2,833,444	2,845,393	2,412,758
Total liabilities	193,635	212,251	335,914	334,130
Total equity	2,384,691	2,621,193	2,509,479	2,078,629

P&L

Year	2025	2024	2023	2022
Total operating income	560,350	936,700	1,340,450	1,260,450
Total operating costs	832,877	840,069	820,121	766,765
Operating result	-272,527	96,631	520,329	493,685
Financial income/costs	36,024	46,676	31,914	-11
Profit before tax	-236,503	143,308	552,243	493,674
Total tax & extraordinary income/cost	0	31,594	121,392	108,595
Annual Total Result	-236,503	111,714	430,851	385,079

Balance overview

Year	2025	2024	2023	2022
Total fixed assets	175,944	175,944	175,944	172,120
Total current assets	2,402,382	2,657,500	2,669,449	2,240,638
Total assets	2,578,326	2,833,444	2,845,393	2,412,758
Short term debt	193,635	212,251	335,914	334,130
Long term debt	0	0	0	0
Total liabilities	193,635	212,251	335,914	334,130
Contributed capital	43,318	43,318	43,318	43,318
Retained earnings	2,341,373	2,577,875	2,466,161	2,035,311
Total equity	2,384,691	2,621,193	2,509,479	2,078,629
Total equity and liabilities	2,578,326	2,833,444	2,845,393	2,412,759

Classification

21st company classification

BETA

Small company

IFH CONSULTING AS921 230 362